HAMP and atherosclerosis: The role of hepcidin in atherosclerosis is particularly important in patients on dialysis since its expression is upregulated due to impaired renal excretion, chronic inflammatory status, iron administration, erythropoietin therapy, and inadequate dialysis [15].